Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) traded up 0.5% during trading on Wednesday. The company traded as high as €35.08 and last traded at €35.00. Approximately 106,616 shares traded hands during trading, an increase of 13% from the average session volume of 94,405 shares. The stock had previously closed at €34.84.
Carl Zeiss Meditec Stock Performance
The firm has a market capitalization of $3.34 billion, a PE ratio of 20.93, a price-to-earnings-growth ratio of 2.83 and a beta of 1.33. The company’s fifty day moving average price is €32.32 and its two-hundred day moving average price is €28.54.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
